COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,799 Articles (22,527 medRxiv, 8,272 bioRxiv)

Most recent first Previous |  Page 2298: Articles 22971-22980  | Next

In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients
Park, J., Kim, H., Kim, S. Y., Kim, Y., Lee, J.-S., Seong, M.-W., Han, D.
10.1101/2020.08.18.255315 — Posted: 2020-08-18
A Lymph Node Targeted Amphiphile Vaccine Induces Potent Cellular and Humoral Immunity to SARS-CoV-2
Steinbuck, M. P., Seenappa, L. M., Jakubowski, A., McNeil, L. K., Haqq, C. M., DeMuth, P. C.
10.1101/2020.08.17.251728 — Posted: 2020-08-18
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
Shahbaz, S., Xu, L., Osman, M., Sligl, W., Shields, J., Joyce, M., Tyrrell, L., Oyegbami, O., Elahi, S.
10.1101/2020.08.18.255927 — Posted: 2020-08-18
Heart disease mortality during the early pandemic period in the United States.
Faust, J. S., Lin, Z., Wright, K. N., Di Iorio, M. A., Walsh, C. D., Krumholz, H.
10.1101/2020.08.16.20175406 — Posted: 2020-08-18 Discussion: Onsite
KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response
Reese, J. T., Unni, D. R., Callahan, T. J., Cappelletti, L., Ravanmehr, V., Carbon, S., Fontana, T., Blau, H., Matentzoglu, N., Harris, N. L., Munoz-Torres, M. C., Robinson, P. N., Joachimiak, M. P., Mungall, C. J.
10.1101/2020.08.17.254839 — Posted: 2020-08-18
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity
Martino, C., Kellman, B. P., Sandoval, D. R., Clausen, T. M., Marotz, C. A., Song, S. J., Wandro, S., Zaramela, L. S., Salido Benitez, R. A., Zhu, Q., Armingol, E., Vazquez-Baeza, Y., McDonald, D., Sorrentino, J. T., Taylor, B., Belda-Ferre, P., Liang, C., Zhang, Y., Schifanella, L., Klatt, N. R., Havulinna, A. S., Jousilahti, P., Huang, S., Haiminen, N., Parida, L., Kim, H.-C., Swafford, A. D., Zengler, K., Cheng, S., Inouye, M., Niiranen, T., Jain, M., Salomaa, V., Esko, J. D., Lewis, N. E., Knight, R.
10.1101/2020.08.17.238444 — Posted: 2020-08-18
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Chen, C. Z., Shinn, P., Itkin, Z., Eastman, R., Bostwick, R., Rasmussen, L., Huang, R., Shen, M., Hu, X., Wilson, K. M., Brooks, B., Guo, H., Zhao, T., Klumpp-Thomas, C., Simeonov, A., Michael, S. G., Lo, D. C., Hall, M., Zheng, W.
10.1101/2020.08.18.255877 — Posted: 2020-08-18
Equine hyperimmune globulin raised against the SARS-CoV-2 spike glycoprotein has extremely high neutralizing titers
Cunha, L. E. R., Stolet, A. A., Strauch, M. A., Pereira, V. A. R., Dumard, C. H., Souza, P. N. C., Fonseca, J. G., Pontes, F. E., Meirelles, L. G. R., Albuquerque, J. W. M., Sacramento, C. Q., Fintelman-Rodrigues, N., Lima, T. M., Alvim, R. G. F., Zingali, R., Oliveira, G. A. P., Souza, T. M. L., TANURI, A., Gomes, A. M. O., Oliveira, A. C., Guedes, H. L. M., Castilho, L. R., Silva, J. L.
10.1101/2020.08.17.254375 — Posted: 2020-08-18
Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City
Caplin, N. J., Zhdanova, O., Tandon, M., Thompson, N., Patel, D., Somroo, Q., Ranjeeta, F., Joseph, L., Scherer, J., Joshi, S., Dyal, B., Chawla, H., Lakshmi, S., Bails, D., Benstein, J., Goldfarb, D. S., Gelb, B., Amerling, R., Charytan, D. M.
10.1101/2020.08.16.20175992 — Posted: 2020-08-18
On the use of growth models for forecasting epidemic outbreaks with application to COVID-19 data
TOVISSODE, C. F., LOKONON, B. E., GLELE KAKAÏ, R.
10.1101/2020.08.16.20176057 — Posted: 2020-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).